Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Granulosa Cell Tumor × orteronel × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 6 Neoplasm Metastasis 2 Granulosa Cell Tumor 1

Interventions

orteronel 1 Nivolumab 1 Ketoconazole 1 BID protein, human 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02101684 2018-03-05

Greko II

Grupo Español de Tumores Huérfanos e Infrecuentes

Phase 2 Terminated

Granulosa Cell Tumor, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡